Anticoagulant Reversal Drugs Market Value Projected to Expand by 2029

 Anticoagulant reversal drugs market is anticipated to grow at a significant CAGR during the forecast period. Anticoagulant reversal drugs come in various drug classes such as prothrombin complex concentrates, coagulation factors, monoclonal antibodies, phytonadione, and other drug classes. In addition to this, the high demand for these drugs from various end-users such as hospitals, pharmacies, retail pharmacies, and others is primarily contributing to the global market growth.

The other key factors contributing to the market growth include a surge in the global prevalence of multiple cardiovascular indications, the increase in intracranial and gastrointestinal haemorrhages, atrial fibrillation, and the constantly rising geriatric population. The mortalities registered due to these diseases too is quite high. As per the World Health Organization, each year an estimated 17.9 million people die due to cardiovascular diseases around the globe. This further indicates the share of 35% of the global mortalities. Additionally, 85% of these cardiovascular disease mortalities are registered due to heart attacks and strokes.

Some key players operating in the market include Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

To Request a Sample of our Report on Anticoagulant Reversal Drugs Market:  https://www.omrglobal.com/request-sample/anticoagulant-reversal-drugs-market

Market Coverage

·        The market number available for – 2021-2029

·        Base year- 2021

·        Forecast period- 2023-2029

·        Segment Covered

·        Regions Covered- Globally

·        Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others.           

Anticoagulant Reversal Drugs Market by Segments 

By Drug Class 

             Prothrombin Complex Concentrates

             Coagulation Factors

             Monoclonal Antibodies

             Phytonadione

             Others 

By End-User 

             Hospital Pharmacies

             Retail Pharmacies

             Others

A full Report of Anticoagulant Reversal Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/anticoagulant-reversal-drugs-market

 Anticoagulant Reversal Drugs Market by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025